209 related articles for article (PubMed ID: 16318875)
41. Correlates of noncompliance among renal transplant recipients.
Frazier PA; Davis-Ali SH; Dahl KE
Clin Transplant; 1994 Dec; 8(6):550-7. PubMed ID: 7865918
[TBL] [Abstract][Full Text] [Related]
42. An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.
Maneesakorn S; Robson D; Gournay K; Gray R
J Clin Nurs; 2007 Jul; 16(7):1302-12. PubMed ID: 17584349
[TBL] [Abstract][Full Text] [Related]
43. Clinical and resource-use outcomes of risperidone long-acting injection in recent and long-term diagnosed schizophrenia patients: results from a multinational electronic registry.
Olivares JM; Peuskens J; Pecenak J; Resseler S; Jacobs A; Akhras KS;
Curr Med Res Opin; 2009 Sep; 25(9):2197-206. PubMed ID: 19604073
[TBL] [Abstract][Full Text] [Related]
44. Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: a 12-month follow up.
Chen CK; Chen YC; Huang YS
Psychiatry Clin Neurosci; 2009 Feb; 63(1):17-22. PubMed ID: 19067997
[TBL] [Abstract][Full Text] [Related]
45. Medication noncompliance and substance abuse among patients with schizophrenia.
Owen RR; Fischer EP; Booth BM; Cuffel BJ
Psychiatr Serv; 1996 Aug; 47(8):853-8. PubMed ID: 8837158
[TBL] [Abstract][Full Text] [Related]
46. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
[TBL] [Abstract][Full Text] [Related]
47. Sociodemographic and clinical factors associated with relapse in schizophrenia.
Chabungbam G; Avasthi A; Sharan P
Psychiatry Clin Neurosci; 2007 Dec; 61(6):587-93. PubMed ID: 18081617
[TBL] [Abstract][Full Text] [Related]
48. [The intercontinental schizophrenia outpatient health outcomes study (IC-SOHO): initial 6 month findings of the sample in Latin America].
Brunner E; Gargoloff P; Caro O; González C; Landa E; González CH; Barahona A; Soria D; Tamayo J; Rovner J; Adrianzen C; Silva H; Hodge A; O'Halloran R; Assunção SS;
Actas Esp Psiquiatr; 2006; 34(1):16-27. PubMed ID: 16525901
[TBL] [Abstract][Full Text] [Related]
49. Psychoeducation and compliance in the treatment of patients with schizophrenia.
Degmecić D; Pozgain I; Filaković P
Coll Antropol; 2007 Dec; 31(4):1111-5. PubMed ID: 18217468
[TBL] [Abstract][Full Text] [Related]
50. Predictors of the course of illness in outpatients with schizophrenia: a prospective three year study.
Haro JM; Novick D; Suarez D; Ochoa S; Roca M
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1287-92. PubMed ID: 18502012
[TBL] [Abstract][Full Text] [Related]
51. Sustaining full recovery in schizophrenia after 15 years: does resilience matter?
Torgalsbøen AK
Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):193-200. PubMed ID: 22182456
[TBL] [Abstract][Full Text] [Related]
52. Chronic ambulatory outpatients and four-vector management.
Am J Manag Care; 1998 Jan; 4 Suppl():S15-9; discussion S20-2. PubMed ID: 10181073
[TBL] [Abstract][Full Text] [Related]
53. Overview of partial compliance.
Marder SR
J Clin Psychiatry; 2003; 64 Suppl 16():3-9. PubMed ID: 14680412
[TBL] [Abstract][Full Text] [Related]
54. Neuroleptic treatment of elderly patients.
Woerner MG; Alvir JM; Kane JM; Saltz BL; Lieberman JA
Psychopharmacol Bull; 1995; 31(2):333-7. PubMed ID: 7491388
[TBL] [Abstract][Full Text] [Related]
55. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia.
Remington G; Kwon J; Collins A; Laporte D; Mann S; Christensen B
Schizophr Res; 2007 Feb; 90(1-3):229-37. PubMed ID: 17208414
[TBL] [Abstract][Full Text] [Related]
56. Predicting medication noncompliance after hospital discharge among patients with schizophrenia.
Olfson M; Mechanic D; Hansell S; Boyer CA; Walkup J; Weiden PJ
Psychiatr Serv; 2000 Feb; 51(2):216-22. PubMed ID: 10655006
[TBL] [Abstract][Full Text] [Related]
57. Attitude to medication of parents/primary carers of people with intellectual disability.
Rasaratnam R; Crouch K; Regan A
J Intellect Disabil Res; 2004 Nov; 48(Pt 8):754-63. PubMed ID: 15494065
[TBL] [Abstract][Full Text] [Related]
58. Risk factors for noncompliance with glaucoma follow-up visits in a residents' eye clinic.
Kosoko O; Quigley HA; Vitale S; Enger C; Kerrigan L; Tielsch JM
Ophthalmology; 1998 Nov; 105(11):2105-11. PubMed ID: 9818613
[TBL] [Abstract][Full Text] [Related]
59. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
[TBL] [Abstract][Full Text] [Related]
60. Predictive value of insight for suicide, violence, hospitalization, and social adjustment for outpatients with schizophrenia: a prospective study.
Yen CF; Yeh ML; Chen CS; Chung HH
Compr Psychiatry; 2002; 43(6):443-7. PubMed ID: 12439831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
